submit to the journals

Posterior Segment Journal Articles, Videos And Insights

Posterior Segment: FEATURED Articles

flipper_slider

Posterior Segment: Latest Articles

US Ophthalmic Review. 2018;11(1): Epub ahead of print.

Posterior Segment: INSIGHTS

The touchOPHTHALMOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of ophthalmology:

Insight
Controversies in the Vascular Mechanisms of Glaucomatous Optic Nerve Disease  Syed Shoeb Ahmad, Ophthalmology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Insight
Minimally Invasive Glaucoma Surgeries (MIGS) Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK
Insight
Novel therapeutic targets in wet AMD Katrina Mountfort, PhD, Freelance Medical Writer, York, UK
ISOPT 2018 HOT TOPIC SESSION REVIEW: MACULAR OEDEMA AND DIABETIC RETINOPATHY
Role of Current Therapies and Insights on Novel Strategies in the Treatment of DMO Presenters: Albert J Augustin, Germany; Baruch D Kuppermann, US; Patricia Udaondo, Spain; Elad Moisseiev, Israel; Albert J Augustin, Germany
ISOPT 2018 HOT TOPIC SESSION: UVEITIS, DRUG DELIVERY and RETINA
Hot Topics in Ophthalmology Presenters: Paul Bernstein, US; Diana V Do, US; Jordi Monés, Spain; Philip J Rosenfeld, US (Retina); John H Kempen, US; Michal Kramer, Israel; Quan Dong Nguyen, US; Marc D de Smet, The Netherlands; Manfred Zierhut, Germany (Uveitis); Abraham Domb, Israel; Ashwath Jayagopal, Switzerland; Arto Urtti, Finland; Clive G Wilson, UK (Drug Delivery)

Posterior Segment: FEATURED VIDEOS

Editor's choice

We took the opportunity to speak with Omar Trabelsi (Clinique Ophthalmologue De Tunis, Tunis, Tunisia) at WOC 2018 about the latest updates and future perspectives of iOC. OCT has only recently found its way into the operating theatres, as a method of providing real-time feedback through image assisted surgery. Dr Trabelsi discusses the advantages and limitations of the technique and equipment so far, and the developments we expect to see in the future. Questions: 1. How is OCT currently used in the operating theatre? (0:21) 2. What are the main advantages of iOCT? (0:59) 3. What are the main limitations of iOCT (2:01) 4. What updates and developments would you like to see happen with iOCT? (2:54) 5. How do you see the future of iOCT? (3:45) Filmed at WOC 2018, June 2018, Barcelona.
Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.

Posterior Segment: Latest Videos

Video List based on Category on Node Page

Latest Videos

At WOC 2018, José Cunha-Vaz (University of Coimbra, Coimbra, Portugal) discussed his experience with treating patients with DME. The most significant developments in the area of DME are OCT imaging and the availability of anti-VEGF agents, which completely revolutionised treatment. The major...
We took the opportunity to speak with Omar Trabelsi (Clinique Ophthalmologue De Tunis, Tunis, Tunisia) at WOC 2018 about the latest updates and future perspectives of iOC. OCT has only recently found its way into the operating theatres, as a method of providing real-time feedback through image...
Francine Behar-Cohen discusses the treatment needs in CNV including effective anti-angiogenic drugs to inhibit the growth and survival of the neovessels and effective control of the scarring process. The introduction of OCT-A has proven useful in the identification of CNV but the real challenge is...
Baruch Kuppermann discusses the challenges of treating patients with dry AMD. Unlike wet AMD, which is responsive to anti-VEGF therapy, there are multiple challenges with wet AMD including the complement pathway and neuroprotection. There is an ongoing search into new ways of tracking wet AMD to...
Baruch Kuppermann discusses integrin peptide therapy and where it may fit within the current treatment regimen for patients with DME.
Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.

LATEST TWEETS

Conference Highlights